Joshua H. Bilenker's most recent trade in Sana Biotechnology Inc was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana Biotechnology Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Joshua H. Bilenker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 11,795 | 11,795 | - | - | Stock Option (Right to Buy) |